Nanosonics share price on watch after tripling its operating profit in FY 2019

The Nanosonics Ltd (ASX:NAN) share price could be on the move today after tripling its operating profit in FY 2019…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price will be one to watch this morning following the announcement of a strong profit result in FY 2019.

What did Nanosonics announce?

For the 12 months to June 30, Nanosonics reported record full year sales of $84.3 million, which was a 39% increase on the prior corresponding period.

This top line result was driven by strong growth in both Capital revenue and Consumable and Service revenue. Capital revenue increased 28% to $32.8 million and Consumables and Service revenue jumped 47% to $51.5 million. The latter reflected the annuity revenue associated with continuing strong growth in the company's installed base.

That installed base continued its solid growth in FY 2019. Management advised that its global installed base reached 20,930 units at the end of the period, which was an 18% increase year on year.

Operating expenses for the year were $49.2 million, including $11.4 million in Research and Development, which was up 16% on prior corresponding period.

This ultimately led to Nanosonics posting operating profit before tax of $16.8 million, which was up a massive 201% on the prior corresponding period.

Nanosonics' Chief Executive Officer and President, Michael Kavanagh, was very pleased with the company's performance in FY 2019.

He said: "The organisation has continued to go from strength to strength delivering excellent growth in our core trophon business while making significant investments in our long term strategy of establishing Nanosonics as a globally recognised leader in infection prevention."

"During the year the 2nd generation trophon, trophon2, was successfully launched receiving very positive customer feedback. Importantly, large investments in our product expansion strategy were made with significant development milestones achieved towards meeting the goal of introducing the first major new product by end of FY20, subject to regulatory approval," added Mr Kavanagh.

Outlook.

In FY 2020 the company expects continued growth in the installed base in North America with an adoption rate similar to FY 2019. It also expects adoption in Europe to grow thanks to its expanded geographical reach and growing awareness.

In addition to this, it advised that its renegotiated distribution agreement with GE Healthcare in the USA has now come into effect. This new agreement expands distribution opportunities globally and also results in a material increase in both sales and margin from consumables in the region. The full impact of which will be realised from the second half of FY 2020.

Operating costs are expected to increase by a sizeable 36% to $67 million this year due to its accelerated investment in growth. This includes $15 million in R&D spending.

Overall, "FY20 profit will be heavily weighted to H2 FY20, taking into consideration: the planned increased investment in new products and geographical expansion of the base trophon business; phasing of trophon sales; and the realisation of consumables margin benefit associated with the new GE Healthcare distribution agreement, the full benefit of which comes into effect in H2 FY20."

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Hub24 Ltd and Nanosonics Limited. The Motley Fool Australia owns shares of and has recommended Wesfarmers Limited. The Motley Fool Australia has recommended Hub24 Ltd and Nanosonics Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Woman with a scared look has hands on her face.
Broker Notes

Bapcor shares fell more than 30% yesterday. Should investors buy in the dip?

Is this a value opportunity?

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Broker raises price targets on 2 ASX 200 shares to buy

Ord Minnett has just upped its 12-month share price targets on 2 buy-rated ASX 200 stocks.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why DroneShield, Gentrack, Metals X, and Northern Star shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Morgans says these ASX can rise 30% to 50%

The broker has good things to say about these shares.

Read more »

Two businessmen look out at the city from the top of a tall building.
Broker Notes

2 ASX REITs to buy in July: expert

Is it time to consider ASX REITs?

Read more »